Further prospective studies are required to establish the actual burden and basic stroke statistics in Maldives Disclosure of interest: Ahmed Rasheed: Nothing to disclose E-Posters - RISK FACTORS - PRIMARY AND SECONDAR PREVENTION 05.00 - RISK FACTORS AND PREVENTION (PRIMARY AND SECONDARY) - 05.02 - SECONDARY PREVENTION P2533 - ESOC25-1487 EFFICACY OF A MULTIDISCIPLINARY OUTPATIENT CLINIC FOR THE INTENSIVE MANAGEMENT OF LDL IN ATHEROTHROMBOTIC ISCHAEMIC STROKE SURVIVORS Reyes De Torres-Chacon 1 , Juan Bautista Loscertales Castaos 1 , Soledad Prez Snchez 1 , Tala Daz Campos 1 , Manuela Bautista Broco 1 , Ana Barragn 1 , Ana Dominguez Mayoral 1 , Miguel Angel Gamero Garcia 1 , Lidia Ruiz Bayo 1 , Joan Montaner 1 Hospital Universitario Virgen Macarena, Seville, Spain Background and Aims: Although persistently high levels of low-density lipoprotein cholesterol (LDL-C) are associated with recurrent atherothrombotic stroke, new lipid-lowering therapies are now available
Emerging research suggests that aggressively inhibiting this enzymeeven with natural supplementsmay inadvertently shut down the production of allopregnanolone , the brains endogenous anti-anxiety and sleep-promoting steroid
Enhanced fat oxidation , promoting efficient energy use
Detoxification Support Lipotropic compounds in each B-12 Lipo-Plus injection play an essential role in assisting liver function
